K. Dzobo

Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)

E. Stroes, S. Tsimikas, J. Kroon, 2020, European heart journal.

Surmounting the endothelial barrier for delivery of drugs and imaging tracers.

E. Stroes, J. Kroon, N. Nurmohamed, 2020, Atherosclerosis.

BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes

S. Wasiak, N. Wong, B. Rakai, 2020, Clinical Epigenetics.

Lipoprotein(a): An underestimated inflammatory mastermind.

J. Kroon, N. Nurmohamed, Jordan M Kraaijenhof, 2022, Atherosclerosis.

A common SNP risk variant MT1-MMP causative for Dupuytren's Disease has a specific defect in collagenolytic activity.

N. Ito, Y. Itoh, Yasuyuki Fujita, 2021, Matrix biology : journal of the International Society for Matrix Biology.

An SNP variant MT1-MMP with a defect in its collagenolytic activity confers the fibrotic phenotype of Dupuytren’s Disease

N. Ito, Y. Itoh, Yasuyuki Fujita, 2020, bioRxiv.

Targeting epigenetics as atherosclerosis treatment: an updated view

L. Willemsen, M. D. de Winther, Hung-Jen Chen, 2020, Current opinion in lipidology.

Elevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy

D. Grobbee, G. Pasterkamp, G. D. de Borst, 2020, Stroke.

Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apnea.

N. de Vries, P. Bresser, H. Verberne, 2022, Atherosclerosis.

Vascular Metabolism as Driver of Atherosclerosis: Linking Endothelial Metabolism to Inflammation

J. Kroon, K. Dzobo, Katie M. L. Hanford, 2021, Immunometabolism.